Active Programs

Expanding Access to Unlicensed Medicines


Tanner Pharma provides access to unregistered products for patients without alternative treatment options. Our Company maintains exclusive agreements with pharmaceutical manufacturers to distribute product in regions on a named patient basis.
Tanner engages a wide network of hospitals, Health authorities, and other institutions to import these medicines for patients in need. With the help of our partners, our goal is to ensure all patients have the necessary medicines at their disposal.

Acetazolamide

Partners:

ADVANZ Pharma

Therapy Area:

Neurology, Ophthalmology

Indication:

Glaucoma, Epilepsy, Cardiac Edema

Bosutinib

Partners:

Pfizer, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia

Crizotinib

Partners:

Pfizer, The Max Foundation

Therapy Area:

Oncology

Indication:

Non-Small-Cell Lung Cancer

Dasatinib

Partners:

Bristol-Myers Squibb, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia

Glycopyrronium

Partners:

Proveca

Therapy Area:

Paediatric Neurology

Indication:

Severe Sialorrhea

Imatinib

Partners:

Novartis, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Gastrointestinal Stromal Tumor

Insulin

Partners:

MannKind Pharmaceuticals

Therapy Area:

Diabetes

Indication:

Type I and II Diabetes

Nilotinib

Partners:

Novartis, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia

Ponatinib

Partners:

Incyte, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia

Ponatinib

Partners:

Takeda, The Max Foundation

Therapy Area:

Oncology

Indication:

Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia

Sargramostim

Partners:

Partner Therapeutics

Therapy Area:

Immunostimulator

Indication:

Bone marrow and stem cell transplant patients

Sunitinib

Partners:

Pfizer, The Max Foundation

Therapy Area:

Oncology

Indication:

Renal Cell Carcinoma

Temsirolimus

Partners:

Pfizer, The Max Foundation

Therapy Area:

Oncology

Indication:

Renal Cell Carcinoma

Urea

Partners:

Nephcentric

Therapy Area:

Medical Food

Indication:

Hyponatremia

If you have any questions regarding our services or the availability of products in your area, please reach out to us directly.

Contact Us

map@tannerpharma.com


General Disclaimer

Please be advised that Tanner Pharma Group makes no representation or guarantee of the validity, accuracy or completeness of the information regarding the products described herein and such information is being provided “AS IS” without warranty of any kind, either express or implied. The use of the product information contained herein may, in some jurisdictions, be restricted by laws and regulations pertaining to the marketing of pharmaceutical products in those jurisdictions; therefore, before using the content in regard to the described products, please ensure that you have the right to use said information under the laws and regulations which apply in the jurisdiction of your intended use. You are solely responsible for ensuring that you comply with all the laws and regulations of the jurisdiction that are applicable to you. For example, if you need specific advice (medical, legal, or regulatory), please seek a professional who is licensed or knowledgeable in that area.